A new study shows that infection with hepatitis C virus (HCV) increases a person’s risk for a highly fatal cancer of the biliary tree, the bile carrying pathway between the liver and pancreas. This finding is in the January issue of Hepatology, a journal published by John Wiley & Sons on behalf of the American Association for the Study of Liver Diseases (AASLD).
More than 4 million Americans are infected with HCV, which causes chronic hepatitis, cirrhosis and liver cancer. However, the associations between the virus and other potentially related cancers are less clear.
To better understand the associations between HCV and these cancers, researchers led by Hashem El-Serag of Baylor College of Medicine, conducted a retrospective cohort study of more than 718,000 U.S. veterans who were treated at Veterans Affairs medical facilities between Oct. 1, 1988 and Sept. 30, 2004. Among them, 146,394 were infected with HCV and 572,293 were not. Uninfected subjects were matched to infected ones by sex, age and type and date of visit.
The researchers followed the subjects for an average of 2.3 years to determine the incidence these cancers. They found that “risk for biliary tree cancer in the HCV-infected cohort, although low (4 per 100,000 person-years), was more than double that in the HCV-uninfected cohort.”
The study is the first to formally examine the association between HCV and pancreatic cancer. It is also the first time a significant association has been detected between HCV and this type of cancer in a large cohort study. The findings may lead to greater examination of rare malignancies.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses
April 24th 2025Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.